DE69020002D1 - Ribonukleotidreduktase-Hemmer. - Google Patents

Ribonukleotidreduktase-Hemmer.

Info

Publication number
DE69020002D1
DE69020002D1 DE69020002T DE69020002T DE69020002D1 DE 69020002 D1 DE69020002 D1 DE 69020002D1 DE 69020002 T DE69020002 T DE 69020002T DE 69020002 T DE69020002 T DE 69020002T DE 69020002 D1 DE69020002 D1 DE 69020002D1
Authority
DE
Germany
Prior art keywords
amino
phe
decapeptide
tyr
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69020002T
Other languages
English (en)
Other versions
DE69020002T2 (de
Inventor
Yvan Guindon
Pierre Lavallee
Sumanas Rakhit
Gregory Paul Cosentino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Mega Boehringer Ingelheim Research Inc
Original Assignee
Bio Mega Boehringer Ingelheim Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim Research Inc filed Critical Bio Mega Boehringer Ingelheim Research Inc
Publication of DE69020002D1 publication Critical patent/DE69020002D1/de
Application granted granted Critical
Publication of DE69020002T2 publication Critical patent/DE69020002T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE69020002T 1989-02-17 1990-02-08 Ribonukleotidreduktase-Hemmer. Expired - Fee Related DE69020002T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000591372A CA1327869C (en) 1989-02-17 1989-02-17 Ribonucleotide reductase inhibitors

Publications (2)

Publication Number Publication Date
DE69020002D1 true DE69020002D1 (de) 1995-07-20
DE69020002T2 DE69020002T2 (de) 1995-12-14

Family

ID=4139636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020002T Expired - Fee Related DE69020002T2 (de) 1989-02-17 1990-02-08 Ribonukleotidreduktase-Hemmer.

Country Status (7)

Country Link
US (1) US5071835A (de)
EP (1) EP0383190B1 (de)
JP (1) JPH02264796A (de)
AT (1) ATE123783T1 (de)
AU (1) AU633543B2 (de)
CA (1) CA1327869C (de)
DE (1) DE69020002T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643636B2 (en) * 1989-07-07 1993-11-18 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain
EP0411333B1 (de) * 1989-07-07 1995-05-31 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure
WO1992013549A1 (en) * 1991-02-07 1992-08-20 Research Corporation Technologies, Inc. Inhibition of cell proliferation by hydrophobic peptides
US5459063A (en) * 1993-10-14 1995-10-17 The University Of Pennsylvania Plasmodium falciparum ribonucleotide reductase DNA
WO1998000532A2 (en) * 1996-07-01 1998-01-08 Wright Jim A Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
US6593305B1 (en) 1996-08-02 2003-07-15 Genesense Technologies Inc. Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
AU2004209579B2 (en) 2003-02-10 2010-03-04 Lorus Therapeutics Inc. Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
ZA200609927B (en) * 2004-05-28 2008-07-30 Unigen Pharmaceuticals Inc Diarylalkanes as potent inhibitors of binuclear enzymes
EP2030615A3 (de) * 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen
KR101988329B1 (ko) 2008-07-21 2019-06-12 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
CA2830993C (en) 2011-03-24 2019-07-02 Unigen, Inc. Compounds and methods for preparation of diarylpropanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448730A (en) * 1981-03-24 1984-05-15 Riet Bartholomeus Van T Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4814432A (en) * 1987-05-22 1989-03-21 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US4845195A (en) * 1987-05-22 1989-07-04 Merck & Co., Inc. Inhibitor of ribonucleotide reductase
US4837304A (en) * 1987-05-22 1989-06-06 Merck & Co., Inc. Inhibitor of ribonucleotide reductase

Also Published As

Publication number Publication date
EP0383190A3 (de) 1991-11-21
US5071835A (en) 1991-12-10
AU633543B2 (en) 1993-02-04
EP0383190A2 (de) 1990-08-22
AU4986790A (en) 1990-08-23
JPH02264796A (ja) 1990-10-29
CA1327869C (en) 1994-03-15
EP0383190B1 (de) 1995-06-14
DE69020002T2 (de) 1995-12-14
ATE123783T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
DE69020002D1 (de) Ribonukleotidreduktase-Hemmer.
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
TW215441B (de)
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
EP0387231A3 (de) Hemmer der Proteasen von Retroviren
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
GR860399B (en) Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids
Doebber et al. Identification of a tripeptidyl aminopeptidase in the anterior pituitary gland: effect on the chemical and biological properties of rat and bovine growth hormones
EP0498784A3 (en) Inhibitors of retroviral protease
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
EP0209848A3 (de) Enzyminhibitoren
Darlak et al. Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R, S)-mercaptomethyl]-4-methylpentanoic acid.
DE3782880D1 (de) Hemmende peptide.
NZ320932A (en) Short forms of chemokine b-8
NZ335879A (en) Somatostatin antagonist peptides having a D-amino acid at the second residue
EP0204328A3 (en) Novel thf compositions
DE50007747D1 (de) N-Acetylaminosäureracemase
NZ511747A (en) Regulatory/unfolding peptides of ezrin
EP0333399A3 (en) C-terminal alfa-amidating enzyme and process for production thereof
DE3882233D1 (de) Gefaessaktive peptide.
Hemmasi et al. THE SOLID‐PHASE SYNTHESIS OF α‐MELANOTROPIN HYDRAZIDE
AR009422A1 (es) Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las cuales estan presentes
SE8901278L (sv) Peptidderivat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee